C.M. Bidwell & Associates’s Entrada Therapeutics TRDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-29	Closed	-$262	–	494
2025 Q1	$262	Sell	29 -183	-86%	-$1.65K	﹤0.01%	431
2024 Q4	$3.67K	Buy	212 +183	+631%	+$3.16K	﹤0.01%	379
2024 Q3	$463	Hold	29	–	–	﹤0.01%	468
2024 Q2	$413	Buy	+29	New	+$413	﹤0.01%	451